Identifying Key Metrics and Analyzing Data on Performance Gaps Enhance MLR Review Processes

 

Leveraging data to refine and enhance the promotional material review (MLR) process has become crucial in the ever-evolving landscape of life sciences. Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly.

How can organizations use data to improve their MLR review processes? What specific metrics and insights should they focus on?

This episode of  “Amend & Progress,” Vodori’s go-to podcast for all things promotional material features Jessy Horrell, VP of Customer Success at Vodori. She joins the host of the show, Annalise Ludtke to discuss the real-time analysis of promotional review data, uncovering insights and exploring how organizations can utilize this data to drive process improvements.

Key Points of Discussion

  • High-Level Metrics: Analyzing key performance indicators (KPIs) such as average job duration, feedback incorporation time, and review duration compared to industry benchmarks.
  • Workload Distribution: Understanding the distribution of tasks among reviewers and identifying potential bottlenecks or resource imbalances.
  • Performance Gaps: Identifying bottom performers and discussing strategies for supporting and improving their performance.

Jessy Horrell serves as the VP of Customer Success at Vodori, where she oversees customer onboarding and ongoing success with Vodori’s products. With a data-driven approach, Jessy helps clients understand and utilize their data to make informed decisions and enhance their MLR processes. Jessy holds a degree in Business Administration and has received numerous accolades for her contributions to customer success in the life sciences industry.

Recent Episodes

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…